Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus

Autoimmunity

Volumn 45, Issue 4, 2012, Pages 271-278

  Pontillo, Alessandra ^a,b   Girardelli, Martina ^c   Kamada, Anselmo J ^b   Pancotto, Joao A T ^a   Donadi, Eduardo A ^a   Crovella, Sergio ^b   Sandrin Garcia, Paula ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Genetic polymorphisms; IL 1 ; inflammasome; NLRP1; SLE

Indexed keywords

INFLAMMASOME;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; RASH; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALLELES; APOPTOSIS REGULATORY PROTEINS; BRAZIL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMASOMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859861944     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.637532     Document Type: Article

References (27)

1. Manson JJ, Isenberg DA. The origin and pathogenic consequences of anti-dsDNA antibodies in systemic lupus erythematosus. Expert Rev Clin Immunol 2006;2(3): 377-385. (Pubitemid 44355569)
2. Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008;358(9):900-909. (Pubitemid 351397089)
3. Crow MK. Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 2008;358(9):956-961. (Pubitemid 351397097)
4. Shaw PJ, McDermott MF, Kanneganti TD. Inflammasomes and autoimmunity. Trends Mol Med 2011;17(2):57-64.
5. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140(6):821-832, Review.
6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
7. Contreras G, RothD, Pardo V, Striker LG, Schultz DR. Lupus nephritis: a clinical review for practicing nephrologists. Clin Nephrol 2002;57:95-107. (Pubitemid 34145192)
8. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincón I, Gronseth G, Rhine CB, Padilla P, McGlasson D. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58(8):1214-1220. (Pubitemid 34411865)
9. Vargas AE, Marrero AR, Salzano FM, et al. Frequency of CCR5delta32 in Brazilian populations. Braz J Med Biol Res 2006;39:321-325.
10. Veit TD, Cordero EA, Mucenic T, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009;18:424-430.
11. Sambrook J, Fritch EF, Maniatis T. Molecular cloning - A laboratory Manual. 2 ed, New York: Cold Spring Harbor Laboratory Press; 1989.
12. Pontillo A, Brandao L, Guimaraes R, et al. Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 2010;43(8):583-589.
13. Pontillo A, Vendramin A, Catamo E, et al. The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am J Gastroenterol 2011;106(3):539-544.
14. Cox DG, Canzian F. Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics 2001;17(8):738-739. (Pubitemid 32851382)
15. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265. (Pubitemid 40202029)
16. Jin Y, Mailloux CM, Gowan K, et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356(12):1216-1225. (Pubitemid 46465597)
17. Magitta NF, Bøe Wolff AS, Johansson S, et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 2009; 10(2):120-124.
18. Nath SK, Kelly JA, Namjou B, et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;69(6):1401-1406. (Pubitemid 33124222)
19. Kummer JA, Broekhuizen R, Everett H, et al. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007;55(5):443-452. (Pubitemid 46668626)
20. Glinsky GV. Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes. Cell Cycle 2008;7(23):3680-3694.
21. Camargo JF, Correa PA, Castiblanco J, et al. Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 2004;5(8):609-614. (Pubitemid 40045298)
22. Muraki Y, Tsutsumi A, Takahashi R, et al. Polymorphisms of IL-1 beta gene in Japanese patients with Sjögren's syndrome and systemic lupus erythematosus. J Rheumatol 2004;31(4): 720-725. (Pubitemid 38451258)
23. Parks CG, Cooper GS, Dooley MA, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004;63(1):91-94. (Pubitemid 38064611)
24. Huang CM, Wu MC, Wu JY, et al. Lack of association of interleukin-1beta gene polymorphisms in Chinese patients with systemic lupus erythematosus. Rheumatol Inter 2002; 21(5):173-175.
25. Parks CG, Pandey JP, Dooley MA, et al. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha- 889 C/T polymorphism. Human Immunol 2004;65(6):622-631. (Pubitemid 38813413)
26. Schiff MH. Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis 2000;59(Suppl 1):i103-i108.
27. Jefferies C, Wynne C, Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease? Nat Rev Immunol 2011;11:617-615.